摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2'-chloro-biphenyl-2-carbonitrile

中文名称
——
中文别名
——
英文名称
2'-chloro-biphenyl-2-carbonitrile
英文别名
2'-Chloro-[1,1'-biphenyl]-2-carbonitrile;2-(2-chlorophenyl)benzonitrile
2'-chloro-biphenyl-2-carbonitrile化学式
CAS
——
化学式
C13H8ClN
mdl
——
分子量
213.666
InChiKey
ZXDYQXRJKNAQJS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    23.8
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    2'-chloro-biphenyl-2-carbonitrile三乙基硼氢化锂 作用下, 以 四氢呋喃 为溶剂, 反应 48.0h, 以87%的产率得到菲啶
    参考文献:
    名称:
    Hydride-Induced Anionic Cyclization: An Efficient Method for the Synthesis of 6-H-Phenanthridines via a Transition-Metal-Free Process
    摘要:
    A novel procedure for hydride-induced anionic cyclization has been developed. It includes the reduction of a biaryl bromo-nitrile with a nucleophilic aromatic substitution (SNAr). A range of polysubstituted 6-H-phenanthridines were so obtained in moderate to good yield with good substrate tolerance. This method involves a concise transition-metal-free process and was applied to synthesize natural alkaloids.
    DOI:
    10.1021/acs.orglett.5b00544
  • 作为产物:
    描述:
    (2-Chlorophenyl)-di(propan-2-yloxy)borane 在 四(三苯基膦)钯 potassium carbonate 作用下, 以 乙醇甲苯 为溶剂, 反应 5.0h, 生成 2'-chloro-biphenyl-2-carbonitrile
    参考文献:
    名称:
    通过原位捕获不稳定的硫代中间体来合成邻位取代的芳基硼酸酯。
    摘要:
    [反应:参见正文]使用2,2,6,6-四甲基哌啶锂(LTMP)与三异丙基硼酸酯(B(OiPr)(3))结合进行原位锂化是一种高效且实验简单的制备方法取代的芳基硼酸酯的制备。温和的反应条件允许存在官能团,例如酯或氰基或卤素取代基,这些官能团通常与在芳烃的定向邻位金属化中使用的条件不兼容。芳基硼酸酯与多种芳基卤化物进行了铃木型交叉偶联,以53-94%的收率提供了联芳基。
    DOI:
    10.1021/ol015598+
点击查看最新优质反应信息

文献信息

  • Rhodium-Catalyzed Carbon–Silicon Bond Activation for Synthesis of Benzosilole Derivatives
    作者:Masahiro Onoe、Katsuaki Baba、Yoonjoo Kim、Yusuke Kita、Mamoru Tobisu、Naoto Chatani
    DOI:10.1021/ja3096174
    日期:2012.11.28
    2-trimethylsilylphenylboronic acid with internal alkynes is developed for the synthesis of 2,3-disubstituted benzosilole derivatives. A range of functional groups, encompassing ketones, esters, amines, aryl bromides, and heteroarenes, are compatible, which provides rapid access to diverse benzosiloles. Sequential 2-fold coupling enables modular synthesis of asymmetrically substituted 1,5-dihydro-1,5-disila-s-indacene
    开发了铑催化的 2-三甲基甲硅烷基苯基硼酸与内部炔烃的偶联反应,用于合成 2,3-二取代的苯并硅氧烷衍生物。包括酮、酯、胺、芳基溴化物和杂芳烃在内的一系列官能团是相容的,从而可以快速获得各种苯并硅氧烷。顺序 2 倍偶联能够模块化合成不对称取代的 1,5-dihydro-1,5-disila-s-indacene,这是一种有机电子学中的 π 扩展分子。就机理而言,该反应涉及三烷基甲硅烷基中的 C(烷基)-Si 键的断裂,这通常需要极其苛刻的活化条件。包括取代基影响在内的机理研究表明,C-Si 键断裂不会通过超配位硅物种进行,而是通过铑介导的活化过程。还证明了该反应在 Si-手性苯甲硅烷的催化不对称合成中的潜在用途。
  • Rational Development of Remote C−H Functionalization of Biphenyl: Experimental and Computational Studies
    作者:Zhoulong Fan、Katherine L. Bay、Xiangyang Chen、Zhe Zhuang、Han Seul Park、Kap‐Sun Yeung、K. N. Houk、Jin‐Quan Yu
    DOI:10.1002/anie.201915624
    日期:2020.3.16
    compounds is reported. Compared to the previous approach of installing a complex U-shaped template to achieve a molecular U-turn and assemble the large-sized cyclophane transition state for the remote C-H activation, a synthetically useful phenyl nitrile functional group could also direct remote meta-C-H activation. This reaction provides a useful method for the modification of biaryl compounds because
    报道了一种简单而有效的腈引导的间-CH烯化、乙酰氧基化和联芳基化合物的碘化。与之前安装复杂的U型模板以实现分子掉头并组装大尺寸环芳过渡态以进行远程CH活化的方法相比,合成有用的苯基腈官能团也可以直接远程间位CH活化。该反应为联芳基化合物的改性提供了一种有用的方法,因为腈基可以很容易地转化为胺、酸、酰胺或其他杂环。值得注意的是,从之前使用大环芳腈模板的结果中无法预期联苯腈的远程间位选择性。DFT 计算研究表明,含有配体的 Pd-Ag 异二聚过渡态 (TS) 有利于所需的远程元选择性。对照实验证明了腈基团的定向作用并排除了非定向元-CH激活的可能性。研究发现,取代的 2-吡啶酮配体在协同金属化-去质子化 (CMD) 过程中协助间位 CH 键断裂的关键。
  • Compounds and compositions for inducing chondrogenesis
    申请人:NOVARTIS AG
    公开号:US10188638B2
    公开(公告)日:2019-01-29
    The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds, and methods of using such compounds for treatment of joint damage or joint injury in a mammal, and for inducing differentiation of mesenchymal stem cells into chondrocytes.
    本发明提供了式 I 的化合物: 或其药学上可接受的盐、同系物或立体异构体,其中变量如本文所定义。本发明进一步提供了包含此类化合物的药物组合物,以及使用此类化合物治疗哺乳动物关节损伤或关节损伤和诱导间充质干细胞分化为软骨细胞的方法。
  • Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression
    作者:Youngjae Kim、Jinsung Tae、Kangho Lee、Hyewhon Rhim、Il Han Choo、Heeyeong Cho、Woo-Kyu Park、Gyochang Keum、Hyunah Choo
    DOI:10.1016/j.bmc.2014.07.026
    日期:2014.9
    5-HT7 receptor (5-HT7R) is a promising target for the treatment of depression and neuropathic pain. 5-HT7R antagonists exhibited antidepressant effects, while the agonists produced strong anti-hyperalgesic effects. In our efforts to discover selective 5-HT7R antagonists or agonists, N-biphenylylmethyl 2-methoxyphenylpiperazinylalkanamides 1 were designed, synthesized, and biologically evaluated against 5-HT7R. Among the synthesized compounds, N-2'-chlorobiphenylylmethyl 2-methoxyphenylpiperazinylpentanamide 1-8 showed the best binding affinity with a Ki value of 8.69nM and it was verified as a novel antagonist according to functional assays. The compound 1-8 was very selective over 5-HT1DR, 5-HT2AR, 5-HT3R, 5-HT5AR and 5-HT6R and moderately selective over 5-HT1AR, 5-HT1BR and 5-HT2CR. The novel 5-HT7R antagonist 1-8 exhibited an antidepressant effect at a dose of 25mg/kg in the forced swimming test in mice and showed a U-shaped dose-response curve which typically appears in 5-HT7R antagonists such as SB-269970 and lurasidone.
  • COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS
    申请人:NOVARTIS AG
    公开号:US20170239227A1
    公开(公告)日:2017-08-24
    The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds, and methods of using such compounds for treatment of joint damage or joint injury in a mammal, and for inducing differentiation of mesenchymal stem cells into chondrocytes.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐